A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of VSV-Indiana HIV Gag Vaccine Given Intramuscularly in Healthy, HIV-1-Uninfected Adult Participants.
Phase of Trial: Phase I
Latest Information Update: 24 Sep 2015
At a glance
- Drugs HIV DNA vaccine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 04 Dec 2012 Results were reported in a Profectus BioSciences media release.
- 04 Dec 2012 Status changed from active, no longer recruiting to completed, as reported in a Profectus BioSciences media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History